GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rubicon Organics Inc (TSXV:ROMJ) » Definitions » Risk Assessment

Rubicon Organics (TSXV:ROMJ) Risk Assessment


View and export this data going back to 2018. Start your Free Trial

What is Rubicon Organics Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Rubicon Organics is: No Data: Cannot be evaluated.


Competitive Comparison of Rubicon Organics's Risk Assessment

For the Drug Manufacturers - Specialty & Generic subindustry, Rubicon Organics's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rubicon Organics's Risk Assessment Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rubicon Organics's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Rubicon Organics's Risk Assessment falls into.



Rubicon Organics  (TSXV:ROMJ) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.


Rubicon Organics Risk Assessment Related Terms

Thank you for viewing the detailed overview of Rubicon Organics's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.


Rubicon Organics Business Description

Traded in Other Exchanges
Address
744 West Hastings Street, Unit 505, Vancouver, BC, CAN, V6C 1A5
Rubicon Organics Inc is engaged in the business of the production and sale of cannabis in Canada. The Company produces and processes organic cannabis at its wholly-owned, federally licensed facility in Delta, British Columbia which it sells under its wholly owned and other licensed brands such as Lab Theory, Wildflower, Homestead Cannabis Supply, 1964 Supply Co, and Simply Bare Organic.
Executives
Lenard Boggio Director
John Pigott Director
Karen Proud Director
Eric Savics 10% Security Holder
Michael Erik Detlefsen Director
Margaret Brodie Director, Senior Officer
Jesse Mcconnell 10% Security Holder, Director, Senior Officer
Pierre Lassonde 10% Security Holder
Peter Doig Senior Officer
John Bryan Disher Director

Rubicon Organics Headlines

No Headlines